research2guidance
US$ 27.65
tirzepatide nafld Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with Dual GIP and GLP-1 receptor
Description
Dont stop taking semaglutide injection without first consulting your doctor
May [Internet]
Survey recruitment took place via an online portal, in an app, and via email
The authors searched Medline and the Cochrane Library for RCTs that assessed a maintenance dose of subcutaneous tirzepatide 5, 10, or 15mg once-weekly or subcutaneous semaglutide 0.5, 1.0, or 2.0mg once-weekly for at least 12 weeks
Phase 3 trials include extended monitoring periods that will provide crucial information over the coming years
Here are some key points to remember: 1
